As of 2025-12-19, the EV/EBITDA ratio of VBI Vaccines Inc (VBIV) is -0.00. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VBIV's latest enterprise value is 0.01 mil USD. VBIV's TTM EBITDA according to its financial statements is -45.59 mil USD. Dividing these 2 quantities gives us the above VBIV EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.1x - 16.6x | 15.3x |
| Forward P/E multiples | 34.6x - 56.0x | 53.9x |
| Fair Price | (10,295.26) - (4,948.16) | (10,301.22) |
| Upside | -15766196.1% - -7577674.3% | -15775314.8% |
| Date | EV/EBITDA |